These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6401693)

  • 1. Safety and immunogenicity of a group 29E meningococcal capsular polysaccharide vaccine in adults.
    Griffiss JM; Brandt BL; Altieri PL; Pier GB; Berman SL
    Infect Immun; 1983 Jan; 39(1):247-52. PubMed ID: 6401693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and immunogenicity of group Y and group W135 meningococcal capsular polysaccharide vaccines in adults.
    Griffiss JM; Brandt BL; Altieri PL; Pier GB; Berman SL
    Infect Immun; 1981 Dec; 34(3):725-32. PubMed ID: 6800954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults.
    Anderson EL; Bowers T; Mink CM; Kennedy DJ; Belshe RB; Harakeh H; Pais L; Holder P; Carlone GM
    Infect Immun; 1994 Aug; 62(8):3391-5. PubMed ID: 8039909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological relationship between the capsular polysaccharides of Neisseria meningitidis serogroups Z and 29E.
    Griffiss JM; Brandt BL
    J Gen Microbiol; 1983 Feb; 129(2):447-52. PubMed ID: 6405009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bactericidal antibody responses of juvenile rhesus monkeys immunized with group B Neisseria meningitidis capsular polysaccharide-protein conjugate vaccines.
    Zollinger WD; Moran EE; Devi SJ; Frasch CE
    Infect Immun; 1997 Mar; 65(3):1053-60. PubMed ID: 9038315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immune response to various doses of group Y and W135 meningococcal polysaccharide vaccines.
    Griffiss JM; Brandt BL; Broud DD
    Infect Immun; 1982 Jul; 37(1):205-8. PubMed ID: 6809627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity in adult males of a Neisseria meningitidis group B vaccine composed of polysaccharide complexed with outer membrane proteins.
    Lifely MR; Roberts SC; Shepherd WM; Esdaile J; Wang Z; Cleverly A; Aulaqi AA; Moreno C
    Vaccine; 1991 Jan; 9(1):60-6. PubMed ID: 1901187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man.
    Zollinger WD; Mandrell RE; Griffiss JM; Altieri P; Berman S
    J Clin Invest; 1979 May; 63(5):836-48. PubMed ID: 109466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class-specific human bactericidal antibodies to capsular and noncapsular surface antigens of Neisseria meningitidis.
    Skevakis L; Frasch CE; Zahradnik JM; Dolin R
    J Infect Dis; 1984 Mar; 149(3):387-96. PubMed ID: 6425422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivity and immunogenicity of bivalent (AC) and tetravalent (ACW135Y) meningococcal vaccines containing O-acetyl-negative or O-acetyl-positive group C polysaccharide.
    Vodopija I; Baklaic Z; Hauser P; Roelants P; André FE; Safary A
    Infect Immun; 1983 Nov; 42(2):599-604. PubMed ID: 6417019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.
    Weinberg GA; Einhorn MS; Lenoir AA; Granoff PD; Granoff DM
    J Pediatr; 1987 Jul; 111(1):22-7. PubMed ID: 3110388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adults.
    Richmond P; Goldblatt D; Fusco PC; Fusco JD; Heron I; Clark S; Borrow R; Michon F
    Vaccine; 1999 Nov; 18(7-8):641-6. PubMed ID: 10547423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total and functional antibody response to a quadrivalent meningococcal polysaccharide vaccine among children.
    King WJ; MacDonald NE; Wells G; Huang J; Allen U; Chan F; Ferris W; Diaz-Mitoma F; Ashton F
    J Pediatr; 1996 Feb; 128(2):196-202. PubMed ID: 8636811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of three doses of a Neisseria meningitidis A + C diphtheria conjugate vaccine in infants from Niger.
    Campagne G; Garba A; Fabre P; Schuchat A; Ryall R; Boulanger D; Bybel M; Carlone G; Briantais P; Ivanoff B; Xerri B; Chippaux JP
    Pediatr Infect Dis J; 2000 Feb; 19(2):144-50. PubMed ID: 10694002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum antibodies to capsular polysaccharide vaccine of group A and C Neisseria meningitidis in military recruits in Italy.
    Occhionero M; Usai G; Di Martino M; Le Moli S; Stroffolini T; Mastrantonio P
    Allergol Immunopathol (Madr); 1991; 19(1):39-41. PubMed ID: 1950941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immune bacteriolysis reaction in the assessment of immunological effectiveness of serogroup B meningococcal vaccine].
    Golovina LI; Kuvakina VI; Alliluev AP; Basnak'ian IA; Sivko RI
    Klin Lab Diagn; 1995; (1):26-9. PubMed ID: 7757362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of immunologic memory by conjugated vs plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial.
    MacDonald NE; Halperin SA; Law BJ; Forrest B; Danzig LE; Granoff DM
    JAMA; 1998 Nov; 280(19):1685-9. PubMed ID: 9832000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neisseria meningitidis serogroup B outer membrane vesicle vaccine in adults with occupational risk for meningococcal disease.
    Fischer M; Carlone GM; Holst J; Williams D; Stephens DS; Perkins BA
    Vaccine; 1999 May; 17(19):2377-83. PubMed ID: 10392619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine.
    Rosenqvist E; Høiby EA; Bjune G; Aase A; Halstensen A; Lehmann AK; Paulssen J; Holst J; Michaelsen TE; Nøkleby H; Frøholm LO; Closs O
    Dev Biol Stand; 1998; 92():323-33. PubMed ID: 9554288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status of meningococcal group B vaccine candidates: capsular or noncapsular?
    Diaz Romero J; Outschoorn IM
    Clin Microbiol Rev; 1994 Oct; 7(4):559-75. PubMed ID: 7834605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.